Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates
Alexandra J. Spencer(University of Oxford), Adrian V. S. Hill(Jenner Institute), Julie Furze(University of Oxford), Christine S. Rollier(University of Oxford), Simon J. Draper(University of Oxford), Sarah C. Gilbert(Nuffield Orthopaedic Centre), F. Hill(Imaxio (France)), Jared Honeycutt(University of Oxford), Matthew G. Cottingham(University of Oxford), Karen C. Søgaard(University of Oxford), David Wyllie(John Radcliffe Hospital), Migena Bregu(University of Oxford)
Cited by 47
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661